Inotuzumab Ozogamacin
Uses
Inotuzumab Ozogamacin is used in the treatment of acute lymphoblastic leukemia.
How it Works
How Inotuzumab Ozogamicin Works Inotuzumab Ozogamicin contains Inotuzumab Ozogamicin, an antineoplastic agent that treats relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukemia (ALL) in adults. It targets the CD22 antigen expressed on immature B-cell lymphocytes and inhibits the growth of tumor cells. This medication restores normal blood counts and aids in achieving complete remission from the disease.
Side Effects
Common side effects of Inotuzumab Ozogamicin include low blood platelets, decreased white blood cell count (neutrophils), infection, anemia (low number of red blood cells), decreased white blood cell count (lymphocytes), fatigue, hemorrhage, fever, nausea, headache, febrile neutropenia, increased transaminase levels in the blood, abdominal pain, increased gamma-glutamyltransferase, and increased bilirubin in the blood.
Expert Advice
- Your doctor may monitor your blood counts and liver function before you start taking Inotuzumab Ozogamacin and regularly throughout your treatment.
- Males and females of reproductive potential should use effective contraception during treatment and for at least five and eight months, respectively, after the last dose.
- Avoid breastfeeding during treatment and for two months after the last dose.
- Inotuzumab Ozogamacin may cause dizziness for the first few days; rise slowly if you have been sitting or lying down for an extended period.
- After starting treatment with Inotuzumab Ozogamacin, you may be at increased risk of infection; therefore, avoid crowds or contact with individuals who have colds.
- Report fever or any other signs of infection immediately to your doctor.
Other Combinations
Flat Rs 100 on first app order | Use Code: APP100 |
Flat Rs 100 on first app order
USE CODE: APP100
Download Now
